May 17th 2024
Since diabetes technology innovation, combined with strong patient demand, has outpaced current evaluation methods, investigators are calling for new approaches that “keep up with the times.”
The Emerging Treatment Landscape for Hemophilia A and the Valuable Role of the Specialty Pharmacist
1.5 Credits / Endocrinology Diabetes & Metabolism
View More
Improving Pharmacists' Knowledge of Endometrial Cancer and Solutions for Equity and Medication Access
1.5 Credits / Endocrinology, Diabetes & Metabolism, Oncology
View More
Delving Into the Latest Integrated Continuous Glucose Monitoring Devices: An Interdisciplinary Approach With Case Discussions to Enhance Diabetes Care
1.5 Credits / Endocrinology Diabetes & Metabolism
View More
Delving Into the Latest Integrated Continuous Glucose Monitoring Devices: An Interdisciplinary Approach With Case Discussions to Enhance Diabetes Care (Pharmacy Technician Cre...
1.5 Credits / Endocrinology Diabetes & Metabolism
View More
Diabetes Management With Integrated Continuous Glucose Monitoring Devices: Pharmacist Best Practices for Individualizing Treatment
0.75 Credit / Endocrinology Diabetes & Metabolism
View More
Background and Key Concepts in Biosimilars: Improving Awareness and Addressing Common Concerns
1.0 Credit / Law
View More
The Role of Integrated Continuous Glucose Monitoring in Improving Clinical Outcomes in Diabetes
0.75 Credit / Endocrinology Diabetes & Metabolism
View More
Clinical Conversations With the Cancer Care Team: Striving for Equitable Access to Oral Anticancer Medications
1.5 Credits / Law, Oncology
View More
Continuous Glucose Monitoring in Diabetes Care: Examining the Value and Addressing Barriers to Access
3.5 Credits / Endocrinology, Diabetes & Metabolism
View More
Introduction to Chronic Kidney Disease in People Living With Type 2 Diabetes: Combating Disease Progression and Complications
1.0 Credit / Endocrinology, Diabetes, and Metabolism, Nephrology
View More
Examining Current and Emerging Therapies to Slow Progression of Chronic Kidney Disease
1.0 Credit / Endocrinology, Diabetes, and Metabolism, Nephrology
View More
Tailoring Recommendations for People Living With Type 2 Diabetes and Chronic Kidney Disease: The Role of the Pharmacist
1.0 Credit / Endocrinology, Diabetes, and Metabolism, Nephrology
View More
Child Abuse: Responsibilities and Protection of the Reporter
1.0 Credit / Law
View More
The Utilization of SGLT2 Inhibitors in the Treatment of Cardiovascular Disease, Diabetes, and Chronic Kidney Disease
1.5 Credits / Cardiology; Endocrinology, Diabetes & Metabolism; Nephrology
View More
Community Pharmacist-Led CGM Programs Can Boost Clinic Revenue While Helping Patients
April 12th 2024Although over 38 million people in the US have diabetes, continuous glucose monitor (CGM) uptake is low. Community pharmacists are uniquely positioned to promote uptake due to their frequent interactions with patients and expertise in chronic condition counseling.
Dexcom Submits New CGM for Non-Insulin Type 2 Diabetes for FDA Clearance
January 30th 2024Although continous glucose monitors (CGMs) have often been tailored to patients with type 1 diabetes, data elicited by these technologies add value to the management of type 2 diabetes by offering insights into patients’ unique responses to food, activity, medications, and more.
Assessing Impact of CGM on Progression of Coronary Atherosclerosis in Patients With T2D
October 31st 2023The OPTIMAL trial assessed the effects of continuous glucose monitoring compared with HbA1c-guided glycemic control on the progression of coronary atherosclerosis in patients with type 2 diabetes mellitus.
Children With T1D Who Report Higher CGM Satisfaction Have Better Glycemic Control
September 18th 2023The 3 most common issues associated with higher satisfaction were “makes adjusting insulin easier,” “helps to keep low blood sugars from happening,” and “makes me feel safer knowing that I will be warned about low blood sugar before it happens.”
Advanced Hybrid Closed-Loop Technology Could Improve Quality of Life in Type 1 Diabetes
September 15th 2023A 1-year observational follow-up of a 3-month randomized controlled trial provides insight into the benefits of advanced hybrid closed-loop system use in people with type 1 diabetes using multiple daily injections and self-monitoring of blood glucose.